ES2170855T3 - Derivados de 1,4-benzodioxina. - Google Patents

Derivados de 1,4-benzodioxina.

Info

Publication number
ES2170855T3
ES2170855T3 ES96913732T ES96913732T ES2170855T3 ES 2170855 T3 ES2170855 T3 ES 2170855T3 ES 96913732 T ES96913732 T ES 96913732T ES 96913732 T ES96913732 T ES 96913732T ES 2170855 T3 ES2170855 T3 ES 2170855T3
Authority
ES
Spain
Prior art keywords
group
sub
hydrogen atom
atom
ariloxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96913732T
Other languages
English (en)
Inventor
Toshihiro Takahashi
Kohei Inomata
Norio Oshida
Nobutoshi Kubota
Tamiko Hamada
Naohito Iwata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Pharma Inc
Original Assignee
Nisshin Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Pharma Inc filed Critical Nisshin Pharma Inc
Application granted granted Critical
Publication of ES2170855T3 publication Critical patent/ES2170855T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE UN DERIVADO DE 1,4 OALQUILO C SUB,3} ALMENTE UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO, UN GRUPO ALQUILO, UN GRUPO TRIFLUOROMETILO, UN GRUPO ALCOXI, UN GRUPO ARILO, UN GRUPO ARILOXI, O R SUB,1} Y R SUB,2} JUNTOS FORMAN UN GRUPO METILENDIOXI, R SUB,3} ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO, R SUB,4} ES UN ATOMO DE HIDROGENO O CO SUB,2}R SUB,5}, R SUB,5} ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO, X ES UN RADICAL DE FORMULA (II) O (III) EN LAS CUALES N ES 1 O 2. LOS COMPUESTOS RESULTAN UTILES PARA UN AGENTE PROFILACTICO O TERAPEUTICO PARA LA DIABETES, LA HIPERGLUCEMIA O LA OBESIDAD.
ES96913732T 1995-05-12 1996-05-13 Derivados de 1,4-benzodioxina. Expired - Lifetime ES2170855T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13744095 1995-05-12

Publications (1)

Publication Number Publication Date
ES2170855T3 true ES2170855T3 (es) 2002-08-16

Family

ID=15198681

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96913732T Expired - Lifetime ES2170855T3 (es) 1995-05-12 1996-05-13 Derivados de 1,4-benzodioxina.

Country Status (8)

Country Link
US (1) US6130243A (es)
EP (1) EP0825189B1 (es)
JP (1) JP3068198B2 (es)
KR (1) KR100490003B1 (es)
CA (1) CA2220759C (es)
DE (1) DE69618634T2 (es)
ES (1) ES2170855T3 (es)
WO (1) WO1996035685A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4967997A (en) 1996-12-02 1998-06-29 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
US5965607A (en) * 1996-12-30 1999-10-12 American Home Products Corporation Substituted Benzo[1,4]dioxines as antiobesity agents
CA2271885A1 (en) * 1996-12-30 1998-07-09 American Home Products Corporation Substituted benzo[1,4]dioxanes as antiobesity agents
DE69938645D1 (de) 1998-07-31 2008-06-19 Nisshin Pharma Inc Optisch aktive 1,4-benzodioxin-2-carbonsäure-derivate und verfahren zu ihrer herstellung
WO2003024953A1 (en) * 2000-08-10 2003-03-27 Nisshin Pharma Inc. Propanolamine derivative having 1,4-benzodioxane ring
JP2002053574A (ja) 2000-08-10 2002-02-19 Nisshin Pharma Inc １，４−ベンゾジオキサン環を有するプロパノールアミン誘導体
US7604206B2 (en) 2001-11-19 2009-10-20 Samsung Electronics Co., Ltd. Monitor improved in a tilting and combining structure
US20030236212A1 (en) * 2002-04-10 2003-12-25 Jean-Louis Dasseux Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses
KR100520060B1 (ko) 2002-05-28 2005-10-11 삼성전자주식회사 모니터장치
AU2003241747A1 (en) * 2002-06-11 2003-12-22 Kaneka Corporation PROCESS FOR PRODUCING OPTICALLY ACTIVE ss-AMINO ALCOHOL
KR100465792B1 (ko) 2002-07-06 2005-01-13 삼성전자주식회사 디스플레이장치
KR100630969B1 (ko) 2002-08-24 2006-10-02 삼성전자주식회사 디스플레이장치
KR100476090B1 (ko) 2002-09-27 2005-03-11 삼성전자주식회사 모니터장치
KR100482007B1 (ko) 2002-09-28 2005-04-13 삼성전자주식회사 모니터장치
KR100770981B1 (ko) 2002-10-30 2007-10-30 삼성전자주식회사 디스플레이의 스탠드
KR100500234B1 (ko) 2002-11-05 2005-07-11 삼성전자주식회사 디스플레이장치
KR100826605B1 (ko) 2002-11-11 2008-04-30 삼성전자주식회사 모니터장치
WO2004070045A1 (ja) * 2003-02-10 2004-08-19 Nisshin Pharma Inc. 光学活性な６－ホルミル－１,４－ベンゾジオキシン－２－カルボン酸誘導体の製造方法
KR100770984B1 (ko) 2003-05-23 2007-10-30 삼성전자주식회사 디스플레이 장치
WO2005083102A1 (ja) * 2004-03-01 2005-09-09 Mercian Corporation 光学活性1,4-ベンゾジオキシン-2-カルボン酸誘導体の製造方法
TW200740779A (en) * 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
WO2007139062A1 (ja) * 2006-05-30 2007-12-06 Kyorin Pharmaceutical Co., Ltd. 肥満治療剤並びに肥満の治療及び予防方法
WO2007145203A1 (ja) * 2006-06-13 2007-12-21 Daiichi Fine Chemical Co., Ltd. 光学活性２－アミノ－１－（４－フルオロフェニル）エタノール
US10052326B1 (en) 2017-10-12 2018-08-21 King Saud University Antihepatotoxic agents
US12492179B2 (en) 2022-12-16 2025-12-09 Enveric Biosciences Canada Inc. Substituted ethylamine fused heterocyclic mescaline derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202818A (en) * 1978-10-16 1980-05-13 Shell Oil Company Lipogenesis inhibition by certain esters of substituted benzodioxincarboxylic acids
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
SG47557A1 (en) * 1993-01-29 1998-04-17 American Cyanamid Co Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents
JPH06293664A (ja) * 1993-04-05 1994-10-21 Fujisawa Pharmaceut Co Ltd β３−アドレナリン作動薬の新規医薬用途
US5482971A (en) * 1993-10-01 1996-01-09 American Cyanamid Company Beta3 -adrenergic agents and their use in pharmaceutical compositions
JPH07228543A (ja) * 1994-02-16 1995-08-29 Fujisawa Pharmaceut Co Ltd β３−アドレナリン作動薬の新規医薬用途

Also Published As

Publication number Publication date
EP0825189A4 (en) 1998-08-05
DE69618634T2 (de) 2002-06-20
KR19990014740A (ko) 1999-02-25
EP0825189B1 (en) 2002-01-02
CA2220759C (en) 2009-01-20
KR100490003B1 (ko) 2005-12-21
JP3068198B2 (ja) 2000-07-24
US6130243A (en) 2000-10-10
DE69618634D1 (de) 2002-02-28
EP0825189A1 (en) 1998-02-25
CA2220759A1 (en) 1996-11-14
WO1996035685A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
ES2170855T3 (es) Derivados de 1,4-benzodioxina.
NO20023995D0 (no) 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse
SE8503680D0 (sv) Indolderivat
YU29892A (sh) Postupak za stereoselektivno dobijanje supstituisanih piperidina
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
ES2059893T3 (es) Derivados de difenilurea.
DK0766668T3 (da) Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf
ES530902A0 (es) Procedimiento para preparar derivados de piperazina
ES529811A0 (es) Procedimiento para preparar derivados de n-fenil-benzamida
FI101376B1 (fi) Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi
DK0550612T3 (da) Ny fremgangsmåde til fremstilling af formoterol ogbeslægtede forbindelser
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
DE3668621D1 (de) Verfahren zur herstellung von pteridinderivaten.
AR000813A1 (es) Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ES2171553T3 (es) Derivados de quinoxalina utiles en terapia.
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
AU8255582A (en) 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol
DK156396C (da) 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse
ES493888A0 (es) Un metodo de preparar derivados de piperidina
DK104388A (da) Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
FI824155A0 (fi) Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren
AR003529A1 (es) Derivados de alfa-fenilpiperidin-1-propanol, procedimiento para su preparacion y su aplicacion terapeutica.
ES2115301T3 (es) Procedimiento para la preparacion de 2-cianoimino-tiazolidina.
DK0521766T3 (da) Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 825189

Country of ref document: ES